A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DA / diffuse astrocytoma

[Related PubMed/MEDLINE]
Total Number of Papers: 52
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DA  (>> Co-occurring Abbreviation)
Long Form:   diffuse astrocytoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas. GAMs, OG, TIME
2020 Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications. AA, GBM, GEP
2020 Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma. CI, HR, IQR, SD
2020 [Diffuse Astrocytoma with Malignant Progression after Long-term Temozolomide Monotherapy:A Case Report]. ---
2019 c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas. AA
2019 Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case Report. AA, PA
2019 Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database. AA, GTR, HR, mIDH, SEER
2019 Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas. LGG, OD
2018 Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults. FRT, PCV, TMZ
10  2018 Cognitive features and surgical outcome of patients with long-term epilepsy-associated tumors (LEATs) within the temporal lobe. AED, DNET, GG, LEATs, PA, PXA
11  2018 Evaluation of DNA ploidy with intraoperative flow cytometry may predict long-term survival of patients with supratentorial low-grade gliomas: Analysis of 102 cases. EOR, iFC, LGG, OD, OS, PFS
12  2018 MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. miR, PA, PLGG
13  2018 p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors. AA, CNS, GB
14  2017 CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression. GBM, RFS, TIL
15  2017 Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. APA
16  2017 Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors. EZH2, GBMs
17  2017 High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients. AA
18  2017 IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over. AA, GBM, IHC, WHO
19  2017 Prognostic value of survivin and DNA topoisomerase IIalpha in diffuse and anaplastic astrocytomas. AA, Ki67, TIIalpha
20  2016 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas. 5hmC, 5mC, TET
21  2016 Expression profiling of RE1-silencing transcription factor (REST), REST corepressor 1 (RCOR1), and Synapsin 1 (SYN1) genes in human gliomas. AO, GBM, RCOR1, RE1, REST, SYN1
22  2016 Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison. CKs, GBM, PA, TMA
23  2016 Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. AA, DIA, GBM, MnSOD, OS, PFS
24  2016 Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers. ---
25  2016 Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades. ---
26  2016 [MRI-characteristics of epileptogenic supratentorial brain tumors in children]. DNET, GG
27  2015 An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals. AA, GBM, KEGG, PAM
28  2015 Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma. IDH1, LGG, MGMT, OA, OG
29  2015 IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy. IDH1, OS, PFS
30  2013 CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas. AA, DFS, GBM, PA, PI, RG
31  2012 BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. PA, WHO
32  2012 Cathepsin D and its prognostic value in neuroepithelial brain tumors. AA, Cath D, GB, MB
33  2012 Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. GT, OG
34  2012 Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. AA, GBM, LI
35  2012 Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status. AA, GBM
36  2012 IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. AA, GBM, WHO
37  2012 IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy. KPS, OA, OL, OS, PFS
38  2012 Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach. EPEN, GBM, OLIG, PA, TMA
39  2011 Factors predicting progression of low-grade diffusely infiltrating astrocytoma. LI, MVD, PFS, WHO
40  2011 Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. AA, AEPN, EPN, GBM, PSCGs, TMZ
41  2010 Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. AA, GBM, IGF
42  2010 Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. AA, EGFR, GBM, LOH
43  2008 Low grade diffuse gliomas: shared cellular composition and morphometric differences. OA, OL
44  2008 Outcome analysis of childhood low-grade astrocytomas. LGA, OS, PA, PFS
45  2007 Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival. AA, AO, GBM, OS, PA, PTN
46  2006 Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas. AA, GBM
47  2006 Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. AA, GBM, PA
48  2005 Apoptosis and proliferation: correlation with p53 in astrocytic tumours. AA, AI, GBM, PI
49  2005 Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas. AA, GB, HNE
50  2005 Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. AA, ASCL1, GBM
51  2004 Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas. AA, GBM
52  2003 Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors. LI, LOH